MediBeacon's mission is to commercialize biocompatible optical diagnostic agents for physiological monitoring, surgical guidance, and imaging of pathological disease in the human population. MediBeacon's optical renal function monitor (ORFM) represents the first real-time point-of-care measurement of renal function targeted at broad adoption in the clinical setting. This noninvasive ORFM system is currently in clinical trials. MediBeacon's extensive Intellectual Property portfolio enables a range of important medical innovations. In addition, MediBeacon has specifically identified fluorescent agents for anatomical visualization in surgery as well as optical dyes with unique characteristics that can prove to be valuable as research tools in the scientific community.